153 related articles for article (PubMed ID: 27313493)
1. Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.
Jan CI; Tsai MH; Chiu CF; Huang YP; Liu CJ; Chang NW
Int J Biol Sci; 2016; 12(7):786-98. PubMed ID: 27313493
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of oral cancer reveals new potential therapeutic targets involved in the Warburg effect.
Huang YP; Chang NW
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):880-887. PubMed ID: 28453233
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model.
Chang NW; Tsai MH; Lin C; Hsu HT; Chu PY; Yeh CM; Chiu CF; Yeh KT
Biochim Biophys Acta; 2011 Apr; 1812(4):558-64. PubMed ID: 21081159
[TBL] [Abstract][Full Text] [Related]
4. Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding.
Quach CH; Jung KH; Lee JH; Park JW; Moon SH; Cho YS; Choe YS; Lee KH
PLoS One; 2016; 11(8):e0159529. PubMed ID: 27479079
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate reduces cisplatin-induced apoptosis of renal proximal tubular cells via inhibition of JNK and p38 pathways.
Thongnuanjan P; Soodvilai S; Chatsudthipong V; Soodvilai S
J Toxicol Sci; 2016; 41(3):339-49. PubMed ID: 27193727
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces a fatal energetic impairment in tumor cells in vitro and in vivo by inhibiting ATP-synthase activity.
Bianchi G; Ravera S; Traverso C; Amaro A; Piaggio F; Emionite L; Bachetti T; Pfeffer U; Raffaghello L
Carcinogenesis; 2018 Sep; 39(9):1141-1150. PubMed ID: 29860383
[TBL] [Abstract][Full Text] [Related]
7. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
9. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
[TBL] [Abstract][Full Text] [Related]
10. AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment.
Daurio NA; Tuttle SW; Worth AJ; Song EY; Davis JM; Snyder NW; Blair IA; Koumenis C
Cancer Res; 2016 Jun; 76(11):3295-306. PubMed ID: 27020861
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.
Wilk A; Wyczechowska D; Zapata A; Dean M; Mullinax J; Marrero L; Parsons C; Peruzzi F; Culicchia F; Ochoa A; Grabacka M; Reiss K
Mol Cell Biol; 2015 Jan; 35(1):182-98. PubMed ID: 25332241
[TBL] [Abstract][Full Text] [Related]
12. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
13. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
Motawi TM; Sadik NA; Fahim SA; Shouman SA
Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
[TBL] [Abstract][Full Text] [Related]
14. An in situ study of bioenergetic properties of human colorectal cancer: the regulation of mitochondrial respiration and distribution of flux control among the components of ATP synthasome.
Kaldma A; Klepinin A; Chekulayev V; Mado K; Shevchuk I; Timohhina N; Tepp K; Kandashvili M; Varikmaa M; Koit A; Planken M; Heck K; Truu L; Planken A; Valvere V; Rebane E; Kaambre T
Int J Biochem Cell Biol; 2014 Oct; 55():171-86. PubMed ID: 25218857
[TBL] [Abstract][Full Text] [Related]
15. The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death.
Liu G; Wang K; Kuang S; Cao R; Bao L; Liu R; Liu H; Sun C
Cell Death Dis; 2018 Jun; 9(6):689. PubMed ID: 29880886
[TBL] [Abstract][Full Text] [Related]
16. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
Grabacka M; Plonka PM; Urbanska K; Reiss K
Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
[TBL] [Abstract][Full Text] [Related]
18. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
[TBL] [Abstract][Full Text] [Related]
19. VDAC electronics: 1. VDAC-hexo(gluco)kinase generator of the mitochondrial outer membrane potential.
Lemeshko VV
Biochim Biophys Acta; 2014 May; 1838(5):1362-71. PubMed ID: 24412217
[TBL] [Abstract][Full Text] [Related]
20. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase.
Goldin N; Arzoine L; Heyfets A; Israelson A; Zaslavsky Z; Bravman T; Bronner V; Notcovich A; Shoshan-Barmatz V; Flescher E
Oncogene; 2008 Aug; 27(34):4636-43. PubMed ID: 18408762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
